Event Schedule
Registration + Networking
Hong Cheng
VP, Head of Research Strategy, Sanofi Research
Sanofi
Opening Keynote: How to Leverage China Innovation to Accelerate Global Discovery, esp. in Pharma
Milad Alucozai
Co-Founder & Board Member
Revalia Bio
Power Panel: "Drug Discovery in 2030"
C-level from Big Pharma, Biotech, Academia, Regulatory, VC
Coffee Break + Micro-Pitch
Startups Pitch in 3-min Rounds
Presentation Session - Block 1A
Small Molecules
Talk 1: Next-Gen Chemistry: Small Molecule Innovation Beyond Traditional Boundaries
Exploring novel scaffolds, fragment-based drug design, and hybrid modalities in modern small molecule discovery.
Partner Slot 1: Structure-Based Drug Design and AI-Driven Optimization
Combining crystallography, modeling, and machine learning to accelerate hit-to-lead progression.
Talk 2: Tackling the Undruggable: Small Molecules Targeting Challenging Proteins
Emerging strategies to drug targets once considered inaccessible, including protein-protein interactions and RNA-binding proteins.
Presentation Session - Block 1B
Biologics + Biosimilars
Philip M Arlen
CEO and Founder
Precision Biologics
Talk 3: The Development of Monoclonal Antibodies Targeting Cancer
Talk 4: Biosimilars in the Spotlight: R&D, Comparability, and Market Readiness
Key insights into biosimilar development pathways, regulatory trends, and analytical characterization.
Partner Slot 2: Engineering for Efficacy: Advances in Biologic Drug Delivery and Stability
Addressing formulation challenges, delivery systems, and bioavailability for next-gen biologics.
Investor Matchmaking Lunch
Thematic Roundtables – Rotation (Tables by Theme)
AI in R&D
Synthetic Biology
Neuroscience and Aging
Medicinal Chemistry
Philip M Arlen
CEO and Founder
Precision Biologics
Panel Discussion: Small Molecules vs. Biologics – The Evolving Drug Discovery Divide
Coffee Break
Snacks + Meet-the-scientist Corners
Presentation Session - Block 2
From Code to Cure: AI in Drug Discovery
Jeff Messer
Director Analytics
GSK
Talk 5: DELve in Practice: 3D Shape-Aware ML to Prioritize DNA-Encoded Library Hits
Partner Slot 3: Generative AI and De Novo Drug Design
Leveraging generative models to create novel chemical entities with drug-like properties.
Talk 6: AI-Driven Target Identification and Validation
Using AI to uncover and validate new biological targets with greater speed and precision.
Talk 7: Optimizing Lead Compounds with Predictive Modeling
How AI tools guide lead optimization by predicting ADMET properties and reducing experimental cycles.
Zoran Krunic
Sr. Manager Data Science
Amgen
Talk 8: Combining AI, Quantum Computing and HPC for Advancing Pharmacology and Clinical Trials
Closing Panel Day 1: “What Investors want: Aligning Science with Market Needs”
Breakfast + Investor Debrief
Lounge Opens Early; Summary of Day 1 Pitches + Meetings
Keynote: Next-Generation Therapeutics & Novel Modalities
Panel: Big Pharma x Startups: “Co-Development & Strategic Investments – What Works?”
Coffee + Innovation Showcase
More 3-min Startup Pitches, Networking Breaks
Presentation Session - Block 3A
Protein Degradation & Molecular Glues
Talk 9: Beyond PROTACs: The Rise of Molecular Glues in Targeted Protein Degradation
Talk 10: Degrader Platforms in Oncology and Immunology
Leenus Martin
Director
Plexium
Talk 11: Discovery and Characterization of CDK2-Selective Molecular Glue Degraders
Presentation Session - Block 3B
Gene Therapy & Genome Editing
Dr. Roshanak T. Semnani
Executive Director Translational Research
Precigen, Inc.
Talk 12: A Novel Gorilla Adenovirus-Based Immunotherapy for RRP in Adults
Talk 13: CRISPR, Base, and Prime Editing: Precision Tools for Tomorrow’s Therapeutics – Latest Advancements in Genome Editing Platforms
Talk 14: Manufacturing and Scalability Challenges in Gene Therapy – Strategies for Improving Yield, Safety, and Clinical Translation
Networking Lunch
IP & Legal Innovation Track: Presentation + Mini-Mock Session: “Patent Battles in Biotech”
Regulatory Deep Dive (EMA/FDA): Panel Discussion: “Navigating Global Pathways”
Coffee + Closing Connection Session
Final Networking Break, Feedback Corner
